Plasma CD93 concentration is a potential novel biomarker for coronary artery disease
Version of Record online: 21 MAR 2011
© 2011 The Association for the Publication of the Journal of Internal Medicine
Journal of Internal Medicine
Volume 270, Issue 3, pages 229–236, September 2011
How to Cite
Mälarstig, A., Silveira, A., Wågsäter, D., Öhrvik, J., Bäcklund, A., Samnegård, A., Khademi, M., Hellenius, M.-L., Leander, K., Olsson, T., Uhlén, M., de Faire, U., Eriksson, P. and Hamsten, A. (2011), Plasma CD93 concentration is a potential novel biomarker for coronary artery disease. Journal of Internal Medicine, 270: 229–236. doi: 10.1111/j.1365-2796.2011.02364.x
- Issue online: 11 AUG 2011
- Version of Record online: 21 MAR 2011
- Accepted manuscript online: 19 FEB 2011 10:39AM EST
Data S1. Methods.
Figure S1. Linkage disequilibrium between CD93 SNPs, as estimated in the HapMap CEU population.
Figure S2. Location and identity of CD93 SNPs examined in the present study.
Figure S3. Distribution of plasma CD93 concentration in the SCARF study.
Table S1. Location and genotyping assay identification numbers for the SNPs genotyped in the present study.
|JOIM_2364_sm_MethodsTabS1-FigS1-S3.doc||95K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.